Why did PHRX.CN stock fall 33% today?

The drop to **C$0.01** reflects weak liquidity, intraday selling pressure and negative fundamentals including EPS **-0.01** and negative book value. Low average volume amplifies price moves during market hours.

What is Meyka AI's rating for PHRX.CN stock?

Meyka AI rates PHRX.CN with a score out of 100: **67.94 (Grade B)** and suggests **HOLD**. This score blends benchmark, sector, financial growth, metrics and analyst consensus.

What price targets and forecast exist for PHRX.CN stock?

Meyka AI's forecast model projects **C$0.01** near term (0.00% implied change). Scenario targets: bear **C$0.005**, base **C$0.01**, bull **C$0.03**. Forecasts are not guarantees.

Are there catalysts that could move PHRX.CN stock?

Yes. Clinical trial updates, new EU distribution contracts, or capital raises could shift sentiment. With tight cash metrics and small float, any news may drive large percentage moves.

CA Stocks

PHRX.CN down 33% to C$0.01 on 19 Feb 2026: what traders should watch

ByHuzaifa Zahoor February 19, 2026February 19, 2026

PHRX.CN stock plunged 33.33% to C$0.01 in market hours on 19 Feb 2026, making Pharmadrug Inc. (PHRX.CN) one of today’s top losers on the CNQ in Canada. The move followed heavy selling after the stock opened at C$0.015 and hit a day low of C$0.01, with 28,921 shares trading vs an average of 37,944. Traders should watch liquidity, short-term technical levels and the company’s weak fundamentals, which explain why volume and price action are driving the decline during regular market hours.